[1] |
Poggio F, Del Mastro L, Bruzzone M, et al. Safety of systemic hormone replacement therapy in breast cancer survivors: a systematic review and Meta-analysis[J]. Breast Cancer Res Treat, 2022, 191: 269-275.
|
[2] |
Sciaraffa T, Guido B, Khan SA, et al. Breast cancer risk assessment and management programs: a practical guide[J]. Breast J, 2020, 26: 1556-1564.
|
[3] |
Tarighati E, Keivan H, Mahani H. A review of prognostic and predictive biomarkers in breast cancer[J]. Clin Exp Med, 2023, 23: 1-16.
|
[4] |
Zhang L, Chen W, Liu S, et al. Targeting breast cancer stem cells[J]. Int J Biol Sci, 2023, 19: 552-570.
|
[5] |
Lu D, Chatterjee S, Xiao K, et al. A circular RNA derived from the insulin receptor locus protects against doxorubicin-induced cardiotoxicity[J]. Eur Heart J, 2022, 43: 4496-4511.
|
[6] |
Tian Y, Zhang Z, Zhang Z, et al. Hsa_circRNA_0040462: a sensor of cells' response to CAP treatment with double-edged roles on breast cancer malignancy[J]. Int J Med Sci, 2022, 19: 640-650.
|
[7] |
何啸, 胡为杰, 吕文昌, 等. 环状RNA在乳腺癌中作用的研究进展[J]. 基础医学与临床, 2022, 42: 507-511.
|
[8] |
Zhou X, Jian W, Luo Q, et al. Circular RNA_0006014 promotes breast cancer progression through sponging miR-885-3p to regulate NTRK2 and PIK3/AKT pathway[J]. Aging (Albany NY), 2022, 14: 3105-3128.
|
[9] |
Zhang L, Zhang W, Zuo Z, et al. Circ_0008673 regulates breast cancer malignancy by miR-153-3p/CFL2 axis [J]. Arch Gynecol Obstet, 2022, 305: 223-232.
|
[10] |
Kan B, Yan G, Shao Y, et al. CircRNA RNF10 inhibits tumorigenicity by targeting miR-942-5p/GOLIM4 axis in breast cancer[J]. Environ Mol Mutagen, 2022, 63: 362-372.
|
[11] |
Guo XY, Liu TT, Zhu WJ, et al. CircKDM4B suppresses breast cancer progression via the miR-675/NEDD4L axis[J]. Oncogene, 2022, 41: 1895-1906.
|
[12] |
Qi L, Sun B, Yang B, et al. circRNA RPPH1 facilitates the aggravation of breast cancer development by regulating miR-542-3p/ARHGAP1 pathway[J]. Cancer Biother Radiopharm, 2022, 37: 708-719.
|
[13] |
Yi G, Wang D, Han J, et al. circKLHL24 blocks breast cancer development by regulating the miR-1204/ALX4 network[J]. Cancer Biother Radiopharm, 2022, 37: 684-696.
|
[14] |
郑彬彬, 林淑莹, 李德隆, 等. 环状RNA ATP2B1靶向miR-452-5p降低胃癌细胞系的增殖和侵袭[J]. 基础医学与临床, 2023, 43: 882-888.
|
[15] |
Hu J, Huang H, Xi Z, et al. LncRNA SEMA3B-AS1 inhibits breast cancer progression by targeting miR-3940/KLLN axis[J]. Cell Death Dis, 2022, 13: 800. doi:10.1038/s41419-022-05189-7.
|